Financial Times FT.com

Isis drug stake set for solid returns

By Martin Arnold, Private Equity Correspondent

Published: November 18 2009 02:00 | Last updated: November 18 2009 02:00

ScriptSwitch, the provider of drug comparison software to doctors' surgeries, has been acquired by UnitedHealth, the leading US healthcare operator, generating a four-fold return for the Coventry-based company's private equity backers.

The sale of ScriptSwitch - founded by two students and a pharmacist at the University of Warwick in 2001 - illustrates how start-up technology companies can still earn big profits for their private equity backers.

You have viewed your allowance of free articles. If you wish to view more, click the button below.

Read this